16. Im happy to. Nkats, now just three years old, was the first new center at nih again, quite a long time and was focused in trying to identify the bottle necks from going from basic science discoveries to benefits. In collaboration with our partners in the private sector. I think initially there were some concerns that nih is becoming a drug company, that really was never the plan and is not happening now. Instead, we are identifying areas of Technology Development that no Single Company could undertake, but working with them, we can give you just one example. The effort to try to figure out when youre developing a new drug, whether its going to be safe in humans or not. Has been a real difficult one. We use animal studies, small animals, large animals. Its not that accurate. Its slow, its expensive. We probably lose drugs along the way because some mouse got a slight liver issue and it probably would have had no relevance to humans but we sort of lose the drug at that point. Wouldnt
Cancer, what we can do about it. But the other component which is a longterm ambitious to be sure effort is this cohort of a million or more americans, which we could be studying for virtually all diseases and knowing that you are a dentist i would certainly include in that such things as periodontal disease. We know the environment and genetic risk are involved in those conditions. But we really havent had a sufficiently large study with appropriate patient participation to be able to get those answers. This should be a way to go there. So thats true for diabetes, for Heart Disease, for alzheimers disease, for virtually every common condition with a million people, youre going to have enough events you should really be able to dissect, what were the biomarkers that warned this would happen what were the environmental factors that played a role. We never had that power before we aim to get it. Thats fascinating stuff, and could really advance the advancement of diseases and cure diseas
President. Let gccc countries have the operation. And this operation became legitimate. And in principle, we supported this operation. And we announced that we can, if they need, we can support, we can give them a Logistic Support and intelligence. So far, we havent received any demand from the coalition. But at the end, turkeys political solution and immediate ceasefire. And humanitarian aid, we are sensitive in that. And broadbased political dialogue. Meaningful dialogue. And possibly National Unity administration or government in yemen. That is what we need. And that is turkeys position. And i was with him in tehran, and he was straight with our iranian counterpart that what iran is doing, their sectarian policy ambitious in the region is not helpful. And not helping their interests either. We were very clear with iran, but we can aaron should also be involved in the process. In this process that i mentioned in yemen. They should also use their influence that they shall withdrawal a
Helping them fight for their own freedom in the sense that we are giving the military aid . Are we still talking about that or actually doing that . In the last 14 months we have provided over 108 million in Security Assistance. I can you do a rundown of what would be included in that, but it would it would be things like medications equipment emergency medical, those kind of things. We will look at what more we can do. That is all nonlethal aid. Are we sending any guns, bullets . No, sir. Why not . They want to defend themselves. As i said we have continued to look at other request from the ukrainians on the lethal side, but note decisions have been made no decisions have been made. So the russians arent each in ukraine, besides being in crimea, which i dont think they will ever try to leave crimea and other nations are very concerned they are next in the russian aggression. I meeting with some ambassadors today. I meeting with some ambassadors today. What is our policy on russian agg
For nearly two decades, how kidney cancer becomes resistant to rapalog drugs has baffled the scientific community. Now a study by researchers at UT Southwe